Special Authority applications approved for emtricitabine with tenofovir disoproxil only
11 June 2021
Dear [name and contact details withheld]
REQUEST FOR INFORMATION
Thank you for your request dated 25 May 2021 under the Official Information Act 1982 (OIA) for information relating to Special Authority applications for emtricitabine with tenofovir disoproxil only. You requested:
The number of approved Special Authority applications (both initial and renewal applications) of emtricitabine with tenofovir disoproxil for the use of pre-exposure prophylaxis (PrEP), for any recent time frame... eg 2020. In particular:
- at a national level
- in the Wellington (CCDHB) region
Please find the information requested provided within the tables below. Please note, these numbers represent the number of approved applications each month, not the number of people being dispensed the medicine each month.
Additionally, we have provided a copy of the source data used to generate these tables. The source data includes a monthly breakdown by DHB of all initial and renewal applications approved in the calendar years 2019 and 2020.
We trust that this information answers your queries. We are making our information more freely available, so we now publish selected OIA responses (excluding personal details) on our website. Please get in touch with us if you have any questions about this.
Yours sincerely
Rachel Read
Manager, Policy and Government Services
Table 1: National Special Authority applications approved for emtricitabine with tenofovir disoproxil only
|
Month |
Initial |
Renewal |
Initial |
Renewal |
|---|---|---|---|---|
|
2019 |
2020 |
|||
|
January |
114 |
304 |
83 |
425 |
|
February |
130 |
309 |
105 |
477 |
|
March |
158 |
364 |
81 |
456 |
|
April |
114 |
370 |
20 |
97 |
|
May |
149 |
418 |
57 |
406 |
|
June |
128 |
375 |
114 |
541 |
|
July |
142 |
419 |
113 |
381 |
|
August |
117 |
390 |
85 |
415 |
|
September |
110 |
402 |
84 |
548 |
|
October |
106 |
438 |
94 |
431 |
|
November |
118 |
465 |
87 |
511 |
|
December |
96 |
453 |
70 |
608 |
|
National total |
1,482 |
4,707 |
993 |
5,296 |
Table 2: Capital and Coast DHB (CCDHB) Special Authority applications approved for emtricitabine with tenofovir disoproxil only
|
Month |
Initial |
Renewal |
Initial |
Renewal |
|---|---|---|---|---|
|
2019 |
2020 |
|||
|
January |
12 |
42 |
14 |
42 |
|
February |
17 |
49 |
14 |
60 |
|
March |
23 |
42 |
13 |
51 |
|
April |
14 |
51 |
3 |
10 |
|
May |
13 |
67 |
4 |
38 |
|
June |
11 |
48 |
15 |
62 |
|
July |
18 |
50 |
17 |
57 |
|
August |
18 |
54 |
12 |
56 |
|
September |
14 |
54 |
11 |
70 |
|
October |
12 |
51 |
14 |
55 |
|
November |
17 |
76 |
6 |
54 |
|
December |
11 |
64 |
14 |
75 |
|
CCDHB total |
180 |
648 |
137 |
630 |